% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Buchert:280229,
      author       = {Buchert, Ralph and Drzezga, Alexander and Schreckenberger,
                      Mathias and Langen, Karl Josef and Meyer, Philipp T},
      collaboration = {Medicine, Working Group Nuclear Neuroimaging of the German
                      Society of Nuclear},
      title        = {{N}eurobildgebung mit {SPECT} und {PET} in {D}eutschland:
                      {E}rgebnisse der 1. {U}mfrage zur nuklearmedizinischen
                      {N}eurobildgebung in {D}eutschland 2023.},
      journal      = {Nuklearmedizin},
      volume       = {64},
      number       = {4},
      issn         = {0029-5566},
      address      = {Stuttgart},
      publisher    = {Thieme},
      reportid     = {DZNE-2025-00907},
      pages        = {250 - 261},
      year         = {2025},
      abstract     = {The advent of disease-modifying therapies for
                      neurodegenerative diseases may result in a growing demand
                      for nuclear neuroimaging procedures presenting opportunities
                      but also challenges to the nuclear medicine community.
                      Whether capacity and expertise in Germany are sufficient to
                      meet an increasing demand for nuclear neuroimaging is under
                      discussion. Against this background, the Neuroimaging
                      Working Group of the German Society of Nuclear Medicine
                      initiated the first survey on the status of nuclear
                      neuroimaging in Germany in 2023. 82 institutions
                      participated in the survey: 33 practices, 15 community
                      hospitals, 34 university hospitals. Primary findings were
                      the following. In practices, brain scans are less frequently
                      performed than in hospitals and are often limited to
                      dopamine transporter SPECT. Brain PET is mainly performed in
                      hospitals, and in community hospitals it is often restricted
                      to FDG PET. Nevertheless, availability of amyloid PET with
                      well-certified quality can be taken for granted. Thus,
                      access to amyloid PET will not be a major bottleneck for new
                      treatments of Alzheimer's disease. Adequate reimbursement
                      and clear anchoring in clinical guidelines have the greatest
                      potential to advance nuclear neuroimaging in Germany.
                      Clinical dopamine transporter SPECT is largely in agreement
                      with procedure guidelines. An area for improvement is the
                      limited availability of MR images to avoid misinterpretation
                      of structural/vascular lesions as nigrostriatal
                      degeneration. The survey provides the first systematic
                      assessment of the status of nuclear neuroimaging in Germany.
                      It underscores the capacity of the German nuclear medicine
                      community to meet an increasing demand for neuroimaging
                      procedures, its adherence to procedure guidelines and
                      identifies topics for improvement.},
      keywords     = {Germany / Humans / Tomography, Emission-Computed,
                      Single-Photon: statistics $\&$ numerical data /
                      Positron-Emission Tomography: statistics $\&$ numerical data
                      / Neuroimaging: statistics $\&$ numerical data /
                      Neuroimaging: methods / Surveys and Questionnaires / Brain:
                      diagnostic imaging},
      cin          = {AG Boecker},
      ddc          = {610},
      cid          = {I:(DE-2719)1011202},
      pnm          = {353 - Clinical and Health Care Research (POF4-353)},
      pid          = {G:(DE-HGF)POF4-353},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:40233814},
      pmc          = {pmc:PMC12328034},
      doi          = {10.1055/a-2566-1487},
      url          = {https://pub.dzne.de/record/280229},
}